June 21, 2007
Osmetech plc has been granted a non-exclusive worldwide diagnostics license from Roche Molecular Systems Inc to use Hot Start polymerase technology in Osmetech nucleic acid diagnostic assays.
The license allows Osmetech to include Hot Start polymerase as part of the diagnostic kit providing Osmetech customers with everything in a kit rather than having the customer source and license components from various vendors.
In 2006 Osmetech launched the eSensor platform, an FDA cleared electrochemistry-based array system for cystic fibrosis carrier detection, and is currently in the process of completing its next generation instrument, the eSensor XT8.
For more information, visit the company’s Web site.
